CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models
- DOI
- 10.1016/j.reth.2025.07.009
- Published
- 2025-12
- Container
- Regenerative Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.reth.2025.07.009,
title = {CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models},
author = {Hamid Khan and Hammad Riaz and Adeel Ahmed and Mubin Mustafa Kiyani and Sahibzada Muhammad Jawad and Syed Shahab Ud Din Shah and Turki Abualait and Fawaz Al-hussain and Hong-Tao Li and Shahid Bashir},
year = {2025},
journal = {Regenerative Therapy},
doi = {10.1016/j.reth.2025.07.009},
url = {https://doi.org/10.1016/j.reth.2025.07.009}
}RIS
TY - JOUR TI - CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models AU - Hamid Khan AU - Hammad Riaz AU - Adeel Ahmed AU - Mubin Mustafa Kiyani AU - Sahibzada Muhammad Jawad AU - Syed Shahab Ud Din Shah AU - Turki Abualait AU - Fawaz Al-hussain AU - Hong-Tao Li AU - Shahid Bashir PY - 2025 JO - Regenerative Therapy DO - 10.1016/j.reth.2025.07.009 UR - https://doi.org/10.1016/j.reth.2025.07.009 ER -
APA
Khan, H., Riaz, H., Ahmed, A., Kiyani, M. M., Jawad, S. M., Shah, S. S. U. D., Abualait, T., Al-hussain, F., Li, H., & Bashir, S. (2025). CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models. Regenerative Therapy. https://doi.org/10.1016/j.reth.2025.07.009
Source records
- crossref · retrieved 2026-09-25T09:01:35.756Z